COVID-19 has vividly demonstrated the risk of a catastrophic biological event. This is magnified by an increasingly interconnected world, challenged by political instability, urbanization, climate change, and new technologies that make it easier, cheaper, and faster to create and engineer pathogens.
NTI joined governments and organizations from around the world for the 2nd Global COVID-19 Summit on May 12, 2022 and committed to provide $35,000 to the pandemic preparedness and global health security financial intermediary fund.
The GHS Index highlights individual country needs, boost compliance with international standards, and create better understanding of global capabilities to prevent, detect, and respond to biological threats.
Preventing global catastrophic biological risks (GCBRS)
Advances in biotechnology outpace national governments’ ability to provide needed oversight to prevent accidents or deliberate misuse of dangerous biological agents.
Reducing biological risk and enhancing global security
Safeguarding modern bioscience and biotechnology so it can advance and flourish safely and responsibly
Rapidly assessing origins of high-consequence global biological events
NTI will host three side events at the 10th NPT Review Conference.
NTI | bio team members join hundreds of global health security experts from around the world in Singapore for the second Global Health Security Conference.
NTI joined governments and organizations from around the world for the 2nd Global COVID-19 Summit on May 12, 2022 and committed to provide $35,000 to the pandemic preparedness and global health security financial intermediary fund.
Report calls on national and global leaders to sustain and expand upon preparedness capacities developed to fight COVID-19
Despite significant steps taken by countries to respond to the COVID-19 pandemic, all countries remain dangerously unprepared to meet future epidemic and pandemic threats.
